Lupin Expects Exeltis Partnership To Boost Solosec
Follows Disappointing Returns And Impairment Linked To Specialty Product
Lupin is hoping that a newly-struck partnership with women’s health specialist Exeltis will improve the fortunes of its Solosec (secnidazole) bacterial vaginosis and trichomoniasis treatment in the US.
